Caris Life Sciences, Inc. Common Stock (CAI) stock news · rev $812.0M
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
This CAI news page leads with what Caris Life Sciences, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for CAI yet. We will not pad this page with generic market recap.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CAI stock page; for the tape open the quote page.
CAI stock news FAQ
What are CAI's latest revenue and net income?
Latest cached Caris Life Sciences, Inc. Common Stock (CAI) revenue for Dec 31, 2025 was $812.0M. Net income was -$68.1M. Statements: https://lician.com/financials/cai
How did CAI revenue change from the prior cached period?
Cached Caris Life Sciences, Inc. Common Stock (CAI) revenue was up 97.0% from $412.3M (Dec 31, 2024) to $812.0M (Dec 31, 2025). Statements: https://lician.com/financials/cai
What is CAI's market cap?
Caris Life Sciences, Inc. Common Stock (CAI) market cap is $5.22B on the latest cached fundamentals snapshot.
What kind of company is CAI?
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Where is CAI stock news listed?
Cached stock news for Caris Life Sciences, Inc. Common Stock (CAI) is listed at https://lician.com/news/cai. Filings: https://lician.com/sec/cai
Not investment advice.